跳至主要内容
临床试验/IRCT20180114038356N2
IRCT20180114038356N2已完成3 期

The effect of resveratrol on hyperlipidemia caused by anti-retroviral drug therapy in HIV patients

Kermanshah University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Sustainable treatment with triple-drug regimen for at least 12 months.
  • LDL> 130 mg / dL or triglyceride 200-500 mg / dL and HDL> 160 mg / dL,
  • with no regular diet and exercise for at least 3 months

排除标准

  • Exclusion criteria were: history of pre-antiretroviral lipid disorders,
  • history of cardiovascular and / or cerebral disease,
  • Cushing's syndrome,
  • hypothyroidism,
  • type 1 or type 2 diabetes,
  • renal failure,
  • previous or current treatment with reduced risk factors. Lipid donors,
  • antihypertensive drugs or estrogens,
  • current drug and / or alcohol abuse.

研究者

相似试验